Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 15;56(6):597–604. doi: 10.2169/internalmedicine.56.7196

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure 3. — The changes in the urinary albumin/creatinine ratio (U-ACR) before and at 3 and 6 months after the start of SGLT2 inhibitor treatment. (a) The patients with a pre-treatment U-ACR of <30 (n=71). (b) The patients with a pre-treatment U-ACR of 30-299 (n=21). (c) The patients with a pre-treatment U-ACR of ≥300 (n=9). * p<0.05, +p<0.01, $ p<0.005, # p<0.001 vs. baseline.